Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context. (2012). Brazilian Journal of Pharmaceutical Sciences, 48(2), 227-236. https://doi.org/10.1590/S1984-82502012000200006